
Sandra laliberte s_laliberte_2001@yahoo.com
25 novembre, 2006 21:42
Breast-Implant Stock Looks Rich
Isn't this what it was all about with the FDA and Health canada approving these I might add with panel members who had a clear conflict and are also in the next while about to also profit from this decision.
I really believe that this time Health Canada and the FDA have finally dug themselves into a hole they won't be able to get out of.
I also suggest any woman who is asked to sign a waiver that lets any plastic surgeon or manufacturer of the hook run out of that office, it is about time women got smarter with there health, with asking Doctors questions and getting the answers and mostly stop ;looking at them like they are god. These particular Doctors are no different than the politicians the have
no ethics, it all boils down to the mighty old buck.
Women get smart!!!!
Sandra
By Johanna Bennett
Word Count: 845 | Companies Featured in This Article: Mentor
WALL STREET PROS like to say, "Buy on the rumor, and sell on the news."
But when the Food and Drug Administration last Friday lifted a 14-year ban on silicone breast implants, investors weren't listening.
Just look at breast-implant maker Mentor's stock, up 12.8% since Friday's close, when the FDA cleared the way for it and rival Allergan to sell new silicone implants for cosmetic purposes in the United States.
Allergan, a more diversified health-care company that is far less dependent on its breast-implant business, didn't get the same boost as Mentor, which generates four-fifths of its revenues from implants. ...